The total return over the past 12 months is -38.75% vs. +16.94% for the S&P 500. So far it's up -8.33% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (35.35%) | (86.33%) | N/A | N/A | N/A | N/A |
| Total Return CAGR | (38.75%) | (86.46%) | N/A | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | (4.47%) | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Allarity Therapeutics, Inc. (ALLR)
| Year | Start price | End price | ALLR Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $1.08 | $1.00 | (8.33%) | +14.51% | (22.84%) |
| 2025 | $1.17 | $1.08 | (7.69%) | +17.72% | (25.41%) |
| 2024 | $330.66 | $1.17 | (99.65%) | +24.89% | (124.54%) |
| 2023 | $246,792.00 | $330.66 | (99.87%) | +26.19% | (126.06%) |
| 2022 | $8,714,580.00 | $246,792.00 | (97.17%) | (18.17%) | (79.00%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
